Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Coated capsules for drug targeting to proximal and distal part of human intestine

K. Dvořáčková, M. Rabišková, J. Gajdziok, D. Vetchý, J. Muselík, J. Bernatoniene, M. Bajerová, P. Drottnerová

. 2010 ; 67 (2) : 191-199.

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025098

Grantová podpora
NS10222 MZ0 CEP - Centrální evidence projektů

Coated hard capsules are becoming increasingly important for a number of reasons such as administration of new active ingredients, oral vaccination, colon drug delivery or their use in preclinical and clinical trials. The independency of coating composition on capsules filling is the major advantage of this dosage form. In our study, two types of hard capsules (gelatin and hypromellose) were coated by non-aqueous solutions of Eudragit L and S 12.5, respectively, to achieve intestinal and distal ileic drug delivery. Gelatin hard capsules were coated with Eudragit film either directly or using hydroxypropyl cellulose sub-coating prior to the final coating. Hypromellose capsules were coated directly. Coated capsules were evaluated for coating thickness by optical microscope and for dissolution in different pH media. Gelatin capsules do not seem to be suitable for direct coating with Eudragit due to insufficient film adhesion to the smooth capsule surface and a brittleness of formed films. These problems can be solved by hydroxypropyl celullose interlayer application. Hypromellose hard capsules could be directly easily coated with both Eudragit solutions. Dissolution of caffeine from coated capsules showed the potency for enteric delivery in gelatin capsules with interlayer and Eudragit L film in 7.5 and 10.0% concentrations and in hypromellose capsules coated with EudragitL in 5-17.5% coating levels. Gelatine capsules with interlayer and 10% Eudragit S film and hypromellose capsules only with high coating level (20%) provided potential distal ileum targeting of incorporated drug. Eudragit S film sprayed onto hypromellose capsules surface was brittle especially in the junction zone between capsule cap and body. Better plasticity of Eudragit S coating could be probably achieved using a different plasticizer.

000      
00000naa a2200000 a 4500
001      
bmc12025098
003      
CZ-PrNML
005      
20221005163027.0
007      
ta
008      
120816s2010 pl f 000 0#eng||
009      
AR
035    __
$a (PubMed)20369797
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Dvořáčková, Kateřina, $d 1973- $7 xx0138801 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
245    10
$a Coated capsules for drug targeting to proximal and distal part of human intestine / $c K. Dvořáčková, M. Rabišková, J. Gajdziok, D. Vetchý, J. Muselík, J. Bernatoniene, M. Bajerová, P. Drottnerová
520    9_
$a Coated hard capsules are becoming increasingly important for a number of reasons such as administration of new active ingredients, oral vaccination, colon drug delivery or their use in preclinical and clinical trials. The independency of coating composition on capsules filling is the major advantage of this dosage form. In our study, two types of hard capsules (gelatin and hypromellose) were coated by non-aqueous solutions of Eudragit L and S 12.5, respectively, to achieve intestinal and distal ileic drug delivery. Gelatin hard capsules were coated with Eudragit film either directly or using hydroxypropyl cellulose sub-coating prior to the final coating. Hypromellose capsules were coated directly. Coated capsules were evaluated for coating thickness by optical microscope and for dissolution in different pH media. Gelatin capsules do not seem to be suitable for direct coating with Eudragit due to insufficient film adhesion to the smooth capsule surface and a brittleness of formed films. These problems can be solved by hydroxypropyl celullose interlayer application. Hypromellose hard capsules could be directly easily coated with both Eudragit solutions. Dissolution of caffeine from coated capsules showed the potency for enteric delivery in gelatin capsules with interlayer and Eudragit L film in 7.5 and 10.0% concentrations and in hypromellose capsules coated with EudragitL in 5-17.5% coating levels. Gelatine capsules with interlayer and 10% Eudragit S film and hypromellose capsules only with high coating level (20%) provided potential distal ileum targeting of incorporated drug. Eudragit S film sprayed onto hypromellose capsules surface was brittle especially in the junction zone between capsule cap and body. Better plasticity of Eudragit S coating could be probably achieved using a different plasticizer.
650    _2
$a tobolky $7 D002214
650    _2
$a systémy cílené aplikace léků $7 D016503
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a ileum $x metabolismus $7 D007082
650    _2
$a kyseliny polymethakrylové $x aplikace a dávkování $7 D011109
650    _2
$a rozpustnost $7 D012995
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rabišková, Miloslava, $d 1951- $7 mzk2005290121
700    1_
$a Gajdziok, Jan $7 xx0126570
700    1_
$a Vetchý, David, $d 1972- $7 mzk2006368163
700    1_
$a Muselík, Jan $7 xx0100243
700    1_
$a Bernatoniene, Jurga $u Department of Drug Technology, Faculty of Pharmacy, Kaunas University of Medicine, Lithuania
700    1#
$a Kejdušová, Martina. $7 xx0176149
700    1#
$a Drottnerová, Pavlína. $7 _AN070825
773    0_
$w MED00000128 $t Acta poloniae pharmaceutica $x 0001-6837 $g Roč. 67, č. 2 (2010), s. 191-199
856    41
$u http://www.ptfarm.pl/pub/File/Acta_Poloniae/2010/2/191.pdf $y plný text volně přístupný
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20221005163022 $b ABA008
999    __
$a ok $b bmc $g 947140 $s 782444
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 67 $c 2 $d 191-199 $i 0001-6837 $m Acta poloniae pharmaceutica $n Acta Pol Pharm $x MED00000128
GRA    __
$a NS10222 $p MZ0
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...